Sarepta shakes up C-suite as they prepare to test FDA on Duchenne again
After slowly losing executives over the last two years, Sarepta has announced a host of changes at its highest level.
Sarepta on Monday announced a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
